Evidence map›Paper›PMID 41755631›Full record

ArticleNucleic acids research2026

Development of a competitive immunoassay platform for quantifying the oligonucleotide products of nucleotide excision repair in UV-irradiated cells.

Geun Hoe Kim, Ha-Jeong Kwon, Youngmin Kim, Michael G Kemp, Jun-Hyuk Choi

Erratum issuedAbstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Geun Hoe KimDivision of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon 305-340, Republic of Korea.ORCID 0000-0001-6855-653X
Ha-Jeong KwonDepartment of Bio-Analytical Science, University of Science & Technology, Daejeon 305-340, Republic of Korea.ORCID 0000-0002-7133-5401
Youngmin KimDivision of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon 305-340, Republic of Korea.ORCID 0009-0004-2094-4268
Michael G KempDepartment of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, United States.ORCID 0000-0001-8203-0745
Jun-Hyuk ChoiDivision of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon 305-340, Republic of Korea.ORCID 0000-0003-2271-949X

Funding

DNA damage response kinase signaling in non-replicating human cells and tissuesR01GM130583 · NIGMS · WRIGHT STATE UNIVERSITY · PI KEMP, MICHAEL GEORGE · 2019 to 2023
$1.5M
CSRD VA I01 CX002241Korea Research Institute of Standards and Science GP2025-0007-1National Research Council of Science and TechnologyNational Research Foundation of Korea CAP22041-100National Research Foundation of Korea NRF-2020R1A2C1101575NIGMS NIH HHS GM130583NIGMS NIH HHS R01 GM130583Veterans Administration I01CX002241Wright State University
6 · The paper itself

Abstract

The nucleotide excision repair (NER) system removes UV photoproducts from the genome in the form of small, excised, damage-containing DNA oligonucleotides (sedDNAs). However, the methods that are traditionally used to detect these repair products in human cells have several limitations, including the presence of other contaminating large DNAs and labeling efficiency. We therefore developed a novel microplate-based competitive immunoassay platform to precisely measure sedDNAs containing pyrimidine (6-4) pyrimidone photoproducts [(6-4)PPs] and cyclobutane pyrimidine dimer (CPD) following UV exposure. The immunoassay employs polyethylene glycol to separate sedDNAs from larger contaminating DNA molecules along with immobilized UV-irradiated oligonucleotides and damage-specific antibodies. Our results demonstrate that this method is highly sensitive and specific, enabling the detection of NER-dependent sedDNAs generated by minimal UV doses and within a short time frame after UV exposure. Moreover, quantification of (6-4)PP- and CPD-containing sedDNAs in this assay allowed the detection of up to 22-fold more (6-4)PP-sedDNAs and up to 7-fold more CPD-sedDNAs than by conventional 3'-end labeling. Thus, this novel immunoassay shows remarkable sensitivity and accuracy for quantifying sedDNAs in UV-irradiated cells and provides a convenient platform for advancing our understanding of the molecular mechanisms of the NER system.

Indexed as

Excision RepairOligonucleotidesUltraviolet RaysDNADNA DamageHumansImmunoassayPyrimidine DimersDNAOligonucleotidesPyrimidine Dimers

Identifiers

PMID41755631
PMCPMC12956346

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.